Prescient Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/08/2024
Prescient Therapeutics Stock Forecast and Price Target
Prescient Therapeutics's most recent price target of $0.14 for 2024 was provided by renowned analysts over the past few months, with an average prediction of $0.14. If this prediction is correct, Prescient Therapeutics's stock could rise by 180 percent from its current trading price. The potential increase for the stock is $0.14 per share, with a possible range of $0.14 to $0.14.
180.00% Upside
Prescient Therapeutics Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Prescient Therapeutics's Revenue has grown by 135.92%, rising from $1.03M to $2.43M. In the following year, 0 experts forecast that Prescient Therapeutics's Revenue will decrease by 24.24%, to $1.84M. In 2030, professionals predict that Prescient Therapeutics's Revenue will decrease by 24.41%, to $1.84M.
.jpg)
Prescient Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
Prescient Therapeutics's EBITDA has seen impressive growth In the last three years, rising from $-3.46M to $-7.46M – a growth of 115.61%. In the following year, the 0 analysts surveyed believe that Prescient Therapeutics's EBITDA will decrease by 22.39%, reaching $-5.79M. According to professionals, by 2030, Prescient Therapeutics's EBITDA will have decreased by 23.21%, falling down to $-5.73M.
Prescient Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Prescient Therapeutics's EBIT has grown by 115.61%, rising from $-3.46M to $-7.46M. The next year, 0 experts forecast that Prescient Therapeutics's EBIT will decrease by 22.39%, reaching $-5.79M. In 2030, professionals predict that Prescient Therapeutics's EBIT will decrease by 23.21%, reaching $-5.73M.
Site Navigation
.jpg)